Evolva Holding SA
Evolva Holding SA ELVAY Peers
See (ELVAY) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ELVAY | $1.16 | N/A | 518242.00 | -0.00 | -$27,905.08 | N/A |
| NONOF | $64.91 | +0.64% | 288.15B | 18.39 | $3.53 | +2.55% |
| CSLLY | $76.65 | +0.58% | 148.46B | 27.97 | $2.74 | +1.73% |
| CMXHF | $146.50 | -3.14% | 70.94B | 26.88 | $5.45 | +1.80% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJY | $85.81 | -1.89% | 33.15B | 27.86 | $3.08 | +0.63% |
| UCBJF | $170.75 | -2.18% | 32.45B | 27.58 | $6.19 | +0.72% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXXWY | $6.01 | +1.86% | 12.21B | 27.32 | $0.22 | N/A |
| WXIBF | $3.00 | N/A | 12.19B | 27.27 | $0.11 | N/A |
Stock Comparison
ELVAY vs NONOF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, NONOF has a market cap of 288.15B. Regarding current trading prices, ELVAY is priced at $1.16, while NONOF trades at $64.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas NONOF's P/E ratio is 18.39. In terms of profitability, ELVAY's ROE is N/A, compared to NONOF's ROE of +0.85%. Regarding short-term risk, ELVAY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CSLLY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CSLLY has a market cap of 148.46B. Regarding current trading prices, ELVAY is priced at $1.16, while CSLLY trades at $76.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CSLLY's P/E ratio is 27.97. In terms of profitability, ELVAY's ROE is N/A, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, ELVAY is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CMXHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CMXHF has a market cap of 70.94B. Regarding current trading prices, ELVAY is priced at $1.16, while CMXHF trades at $146.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CMXHF's P/E ratio is 26.88. In terms of profitability, ELVAY's ROE is N/A, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ELVAY is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ARGNF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, ELVAY is priced at $1.16, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, ELVAY's ROE is N/A, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, ELVAY and ARGNF have similar daily volatility (0.00).
ELVAY vs UCBJY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, UCBJY has a market cap of 33.15B. Regarding current trading prices, ELVAY is priced at $1.16, while UCBJY trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas UCBJY's P/E ratio is 27.86. In terms of profitability, ELVAY's ROE is N/A, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ELVAY is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs UCBJF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, UCBJF has a market cap of 32.45B. Regarding current trading prices, ELVAY is priced at $1.16, while UCBJF trades at $170.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas UCBJF's P/E ratio is 27.58. In terms of profitability, ELVAY's ROE is N/A, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ELVAY is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ODTC Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, ELVAY is priced at $1.16, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ELVAY's ROE is N/A, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ELVAY and ODTC have similar daily volatility (0.00).
ELVAY vs WXXWY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, WXXWY has a market cap of 12.21B. Regarding current trading prices, ELVAY is priced at $1.16, while WXXWY trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas WXXWY's P/E ratio is 27.32. In terms of profitability, ELVAY's ROE is N/A, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ELVAY is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs WXIBF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, ELVAY is priced at $1.16, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, ELVAY's ROE is N/A, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ELVAY and WXIBF have similar daily volatility (0.00).
ELVAY vs GNMSF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, GNMSF has a market cap of 11.61B. Regarding current trading prices, ELVAY is priced at $1.16, while GNMSF trades at $188.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas GNMSF's P/E ratio is 10.26. In terms of profitability, ELVAY's ROE is N/A, compared to GNMSF's ROE of +0.24%. Regarding short-term risk, ELVAY is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs IVBXF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, IVBXF has a market cap of 9.80B. Regarding current trading prices, ELVAY is priced at $1.16, while IVBXF trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas IVBXF's P/E ratio is -594.00. In terms of profitability, ELVAY's ROE is N/A, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ELVAY is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs SBMFF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SBMFF has a market cap of 8.82B. Regarding current trading prices, ELVAY is priced at $1.16, while SBMFF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SBMFF's P/E ratio is 49.30. In terms of profitability, ELVAY's ROE is N/A, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ELVAY is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs SBHMY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, ELVAY is priced at $1.16, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, ELVAY's ROE is N/A, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ELVAY is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs TLPPF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, TLPPF has a market cap of 5.85B. Regarding current trading prices, ELVAY is priced at $1.16, while TLPPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas TLPPF's P/E ratio is 192.22. In terms of profitability, ELVAY's ROE is N/A, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ELVAY and TLPPF have similar daily volatility (0.00).
ELVAY vs ABCZF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, ELVAY is priced at $1.16, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ELVAY's ROE is N/A, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ELVAY and ABCZF have similar daily volatility (0.00).
ELVAY vs INCPF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, ELVAY is priced at $1.16, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ELVAY's ROE is N/A, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ELVAY and INCPF have similar daily volatility (0.00).
ELVAY vs AKBLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, ELVAY is priced at $1.16, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas AKBLF's P/E ratio is 38.13. In terms of profitability, ELVAY's ROE is N/A, compared to AKBLF's ROE of +0.16%. Regarding short-term risk, ELVAY is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs LABFF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, ELVAY is priced at $1.16, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ELVAY's ROE is N/A, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ELVAY and LABFF have similar daily volatility (0.00).
ELVAY vs ZLDPF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ZLDPF has a market cap of 4.40B. Regarding current trading prices, ELVAY is priced at $1.16, while ZLDPF trades at $62.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ZLDPF's P/E ratio is -25.28. In terms of profitability, ELVAY's ROE is N/A, compared to ZLDPF's ROE of -0.15%. Regarding short-term risk, ELVAY is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CAMRF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CAMRF has a market cap of 3.82B. Regarding current trading prices, ELVAY is priced at $1.16, while CAMRF trades at $65.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CAMRF's P/E ratio is 88.04. In terms of profitability, ELVAY's ROE is N/A, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ELVAY is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs SHJBF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, ELVAY is priced at $1.16, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, ELVAY's ROE is N/A, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ELVAY and SHJBF have similar daily volatility (0.00).
ELVAY vs REGMF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, REGMF has a market cap of 3.32B. Regarding current trading prices, ELVAY is priced at $1.16, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ELVAY's ROE is N/A, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ELVAY is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs GNNSF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, ELVAY is priced at $1.16, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, ELVAY's ROE is N/A, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ELVAY is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs TKBIF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, ELVAY is priced at $1.16, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ELVAY's ROE is N/A, compared to TKBIF's ROE of N/A. Regarding short-term risk, ELVAY and TKBIF have similar daily volatility (0.00).
ELVAY vs MPSYF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, ELVAY is priced at $1.16, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ELVAY's ROE is N/A, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, ELVAY is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ASPHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, ELVAY is priced at $1.16, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ELVAY's ROE is N/A, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ELVAY and ASPHF have similar daily volatility (0.00).
ELVAY vs BVNKF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, ELVAY is priced at $1.16, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BVNKF's P/E ratio is 14.03. In terms of profitability, ELVAY's ROE is N/A, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, ELVAY is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs TRSBF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, TRSBF has a market cap of 1.95B. Regarding current trading prices, ELVAY is priced at $1.16, while TRSBF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas TRSBF's P/E ratio is 9.20. In terms of profitability, ELVAY's ROE is N/A, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ELVAY and TRSBF have similar daily volatility (0.00).
ELVAY vs BTTAY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, ELVAY is priced at $1.16, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BTTAY's P/E ratio is 65.49. In terms of profitability, ELVAY's ROE is N/A, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ELVAY is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs BVNRY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BVNRY has a market cap of 1.85B. Regarding current trading prices, ELVAY is priced at $1.16, while BVNRY trades at $7.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BVNRY's P/E ratio is 12.60. In terms of profitability, ELVAY's ROE is N/A, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, ELVAY is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs MEOBF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, ELVAY is priced at $1.16, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, ELVAY's ROE is N/A, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ELVAY is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs GENSF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, GENSF has a market cap of 1.78B. Regarding current trading prices, ELVAY is priced at $1.16, while GENSF trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas GENSF's P/E ratio is -338.75. In terms of profitability, ELVAY's ROE is N/A, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ELVAY is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs PPTDF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, ELVAY is priced at $1.16, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PPTDF's P/E ratio is 16.91. In terms of profitability, ELVAY's ROE is N/A, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ELVAY is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs BRCTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BRCTF has a market cap of 1.62B. Regarding current trading prices, ELVAY is priced at $1.16, while BRCTF trades at $18.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BRCTF's P/E ratio is -87.38. In terms of profitability, ELVAY's ROE is N/A, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ELVAY and BRCTF have similar daily volatility (0.00).
ELVAY vs BIESF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BIESF has a market cap of 1.60B. Regarding current trading prices, ELVAY is priced at $1.16, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BIESF's P/E ratio is 43.24. In terms of profitability, ELVAY's ROE is N/A, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ELVAY and BIESF have similar daily volatility (0.00).
ELVAY vs ONTTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ONTTF has a market cap of 1.58B. Regarding current trading prices, ELVAY is priced at $1.16, while ONTTF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ONTTF's P/E ratio is -7.84. In terms of profitability, ELVAY's ROE is N/A, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ELVAY is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs GLPGF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, GLPGF has a market cap of 1.48B. Regarding current trading prices, ELVAY is priced at $1.16, while GLPGF trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas GLPGF's P/E ratio is -7.25. In terms of profitability, ELVAY's ROE is N/A, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ELVAY is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs PHMMF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, ELVAY is priced at $1.16, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PHMMF's P/E ratio is 63.21. In terms of profitability, ELVAY's ROE is N/A, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ELVAY is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CSBTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, ELVAY is priced at $1.16, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, ELVAY's ROE is N/A, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ELVAY and CSBTF have similar daily volatility (0.00).
ELVAY vs NURPF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, ELVAY is priced at $1.16, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas NURPF's P/E ratio is 11.63. In terms of profitability, ELVAY's ROE is N/A, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ELVAY is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ASCLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, ELVAY is priced at $1.16, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, ELVAY's ROE is N/A, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ELVAY is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CSPHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, ELVAY is priced at $1.16, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, ELVAY's ROE is N/A, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ELVAY is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs PHGUF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PHGUF has a market cap of 621.12M. Regarding current trading prices, ELVAY is priced at $1.16, while PHGUF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PHGUF's P/E ratio is -45.65. In terms of profitability, ELVAY's ROE is N/A, compared to PHGUF's ROE of -0.05%. Regarding short-term risk, ELVAY is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs BPMUF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, ELVAY is priced at $1.16, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BPMUF's P/E ratio is 6.79. In terms of profitability, ELVAY's ROE is N/A, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ELVAY is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs INRLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, ELVAY is priced at $1.16, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas INRLF's P/E ratio is -36.11. In terms of profitability, ELVAY's ROE is N/A, compared to INRLF's ROE of -0.06%. Regarding short-term risk, ELVAY and INRLF have similar daily volatility (0.00).
ELVAY vs SOLTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, ELVAY is priced at $1.16, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, ELVAY's ROE is N/A, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ELVAY is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CYDY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CYDY has a market cap of 514.74M. Regarding current trading prices, ELVAY is priced at $1.16, while CYDY trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CYDY's P/E ratio is -20.88. In terms of profitability, ELVAY's ROE is N/A, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ELVAY is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs IVEVF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, ELVAY is priced at $1.16, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ELVAY's ROE is N/A, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ELVAY and IVEVF have similar daily volatility (0.00).
ELVAY vs CLTEF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, ELVAY is priced at $1.16, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ELVAY's ROE is N/A, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, ELVAY and CLTEF have similar daily volatility (0.00).
ELVAY vs VBIZF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, ELVAY is priced at $1.16, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, ELVAY's ROE is N/A, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ELVAY and VBIZF have similar daily volatility (0.00).
ELVAY vs SNBIF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, ELVAY is priced at $1.16, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ELVAY's ROE is N/A, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ELVAY is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CKDXF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, ELVAY is priced at $1.16, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ELVAY's ROE is N/A, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ELVAY is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs AAVXF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, ELVAY is priced at $1.16, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas AAVXF's P/E ratio is -2.27. In terms of profitability, ELVAY's ROE is N/A, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, ELVAY and AAVXF have similar daily volatility (0.00).
ELVAY vs TBGNF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, ELVAY is priced at $1.16, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ELVAY's ROE is N/A, compared to TBGNF's ROE of N/A. Regarding short-term risk, ELVAY and TBGNF have similar daily volatility (0.00).
ELVAY vs BXPHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BXPHF has a market cap of 429.87M. Regarding current trading prices, ELVAY is priced at $1.16, while BXPHF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BXPHF's P/E ratio is -22.00. In terms of profitability, ELVAY's ROE is N/A, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ELVAY is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs HBMHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, ELVAY is priced at $1.16, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, ELVAY's ROE is N/A, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ELVAY and HBMHF have similar daily volatility (0.00).
ELVAY vs PTCHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PTCHF has a market cap of 396.31M. Regarding current trading prices, ELVAY is priced at $1.16, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, ELVAY's ROE is N/A, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ELVAY and PTCHF have similar daily volatility (0.00).
ELVAY vs NWBO Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, NWBO has a market cap of 390.17M. Regarding current trading prices, ELVAY is priced at $1.16, while NWBO trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas NWBO's P/E ratio is -4.01. In terms of profitability, ELVAY's ROE is N/A, compared to NWBO's ROE of +1.24%. Regarding short-term risk, ELVAY is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CLVLY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CLVLY has a market cap of 350.87M. Regarding current trading prices, ELVAY is priced at $1.16, while CLVLY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CLVLY's P/E ratio is 14.00. In terms of profitability, ELVAY's ROE is N/A, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ELVAY and CLVLY have similar daily volatility (0.00).
ELVAY vs CLVLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, ELVAY is priced at $1.16, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, ELVAY's ROE is N/A, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ELVAY is less volatile compared to CLVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs IDRSF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, IDRSF has a market cap of 337.12M. Regarding current trading prices, ELVAY is priced at $1.16, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas IDRSF's P/E ratio is -0.85. In terms of profitability, ELVAY's ROE is N/A, compared to IDRSF's ROE of +0.29%. Regarding short-term risk, ELVAY and IDRSF have similar daily volatility (0.00).
ELVAY vs PRRUF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, ELVAY is priced at $1.16, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, ELVAY's ROE is N/A, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ELVAY is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs BOVNF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, ELVAY is priced at $1.16, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, ELVAY's ROE is N/A, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ELVAY and BOVNF have similar daily volatility (0.00).
ELVAY vs PBBIF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, ELVAY is priced at $1.16, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ELVAY's ROE is N/A, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ELVAY is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ORYZF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, ELVAY is priced at $1.16, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ELVAY's ROE is N/A, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ELVAY and ORYZF have similar daily volatility (0.00).
ELVAY vs NWPHF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, ELVAY is priced at $1.16, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ELVAY's ROE is N/A, compared to NWPHF's ROE of N/A. Regarding short-term risk, ELVAY and NWPHF have similar daily volatility (0.00).
ELVAY vs MDCLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, ELVAY is priced at $1.16, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, ELVAY's ROE is N/A, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ELVAY is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs HLOSF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, ELVAY is priced at $1.16, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas HLOSF's P/E ratio is -6.82. In terms of profitability, ELVAY's ROE is N/A, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ELVAY is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs SPHDF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, ELVAY is priced at $1.16, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SPHDF's P/E ratio is -3.96. In terms of profitability, ELVAY's ROE is N/A, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ELVAY is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs RAONF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, ELVAY is priced at $1.16, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas RAONF's P/E ratio is -20.33. In terms of profitability, ELVAY's ROE is N/A, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ELVAY is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs FPHAF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, ELVAY is priced at $1.16, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ELVAY's ROE is N/A, compared to FPHAF's ROE of N/A. Regarding short-term risk, ELVAY and FPHAF have similar daily volatility (0.00).
ELVAY vs VSBC Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, ELVAY is priced at $1.16, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas VSBC's P/E ratio is N/A. In terms of profitability, ELVAY's ROE is N/A, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ELVAY and VSBC have similar daily volatility (0.00).
ELVAY vs FGHQF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, ELVAY is priced at $1.16, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ELVAY's ROE is N/A, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ELVAY is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs HNSBF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, ELVAY is priced at $1.16, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, ELVAY's ROE is N/A, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ELVAY is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs AVCTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, AVCTF has a market cap of 199.39M. Regarding current trading prices, ELVAY is priced at $1.16, while AVCTF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas AVCTF's P/E ratio is -4.33. In terms of profitability, ELVAY's ROE is N/A, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ELVAY is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs BSEM Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BSEM has a market cap of 195.90M. Regarding current trading prices, ELVAY is priced at $1.16, while BSEM trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BSEM's P/E ratio is -25.51. In terms of profitability, ELVAY's ROE is N/A, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ELVAY is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs NGENF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, NGENF has a market cap of 182.35M. Regarding current trading prices, ELVAY is priced at $1.16, while NGENF trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas NGENF's P/E ratio is -9.85. In terms of profitability, ELVAY's ROE is N/A, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ELVAY is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs GNFTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, ELVAY is priced at $1.16, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, ELVAY's ROE is N/A, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ELVAY is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs SCNLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, ELVAY is priced at $1.16, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, ELVAY's ROE is N/A, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ELVAY and SCNLF have similar daily volatility (0.00).
ELVAY vs OPORF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, ELVAY is priced at $1.16, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas OPORF's P/E ratio is 12.00. In terms of profitability, ELVAY's ROE is N/A, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ELVAY is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs MLLCF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, ELVAY is priced at $1.16, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas MLLCF's P/E ratio is -2.19. In terms of profitability, ELVAY's ROE is N/A, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ELVAY is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs RECEF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, ELVAY is priced at $1.16, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas RECEF's P/E ratio is -10.00. In terms of profitability, ELVAY's ROE is N/A, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ELVAY is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs IUGNF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, IUGNF has a market cap of 141.87M. Regarding current trading prices, ELVAY is priced at $1.16, while IUGNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas IUGNF's P/E ratio is -1.90. In terms of profitability, ELVAY's ROE is N/A, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ELVAY is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs BRIBF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, ELVAY is priced at $1.16, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, ELVAY's ROE is N/A, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ELVAY and BRIBF have similar daily volatility (0.00).
ELVAY vs IPHYF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, ELVAY is priced at $1.16, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, ELVAY's ROE is N/A, compared to IPHYF's ROE of -0.84%. Regarding short-term risk, ELVAY is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs AAPGV Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, ELVAY is priced at $1.16, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ELVAY's ROE is N/A, compared to AAPGV's ROE of N/A. Regarding short-term risk, ELVAY is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs PRNAF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, ELVAY is priced at $1.16, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, ELVAY's ROE is N/A, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, ELVAY and PRNAF have similar daily volatility (0.00).
ELVAY vs AMGXF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, ELVAY is priced at $1.16, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ELVAY's ROE is N/A, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ELVAY is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs PSTTF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, ELVAY is priced at $1.16, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ELVAY's ROE is N/A, compared to PSTTF's ROE of N/A. Regarding short-term risk, ELVAY and PSTTF have similar daily volatility (0.00).
ELVAY vs EPRXF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, ELVAY is priced at $1.16, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ELVAY's ROE is N/A, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, ELVAY is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ADOIF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, ELVAY is priced at $1.16, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ELVAY's ROE is N/A, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ELVAY and ADOIF have similar daily volatility (0.00).
ELVAY vs ADOCY Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, ELVAY is priced at $1.16, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ELVAY's ROE is N/A, compared to ADOCY's ROE of +1.28%. Regarding short-term risk, ELVAY and ADOCY have similar daily volatility (0.00).
ELVAY vs TRGNF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, ELVAY is priced at $1.16, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, ELVAY's ROE is N/A, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ELVAY is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs CMVLF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, ELVAY is priced at $1.16, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, ELVAY's ROE is N/A, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ELVAY is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs MCURF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, ELVAY is priced at $1.16, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ELVAY's ROE is N/A, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ELVAY is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs PBIGF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, PBIGF has a market cap of 83.73M. Regarding current trading prices, ELVAY is priced at $1.16, while PBIGF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas PBIGF's P/E ratio is -7.17. In terms of profitability, ELVAY's ROE is N/A, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ELVAY is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for ELVAY.
ELVAY vs ACHFF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ACHFF has a market cap of 80.41M. Regarding current trading prices, ELVAY is priced at $1.16, while ACHFF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ACHFF's P/E ratio is -30.50. In terms of profitability, ELVAY's ROE is N/A, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, ELVAY and ACHFF have similar daily volatility (0.00).
ELVAY vs KNTPF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, ELVAY is priced at $1.16, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, ELVAY's ROE is N/A, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, ELVAY and KNTPF have similar daily volatility (0.00).
ELVAY vs ETXPF Comparison
ELVAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ELVAY stands at 518242.00. In comparison, ETXPF has a market cap of 75.96M. Regarding current trading prices, ELVAY is priced at $1.16, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ELVAY currently has a P/E ratio of -0.00, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, ELVAY's ROE is N/A, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, ELVAY and ETXPF have similar daily volatility (0.00).